ATHENEX PHARMACEUTICAL DIVISION — Furosemide Importer Profile
Pharmaceutical Importer · #10 buyer for Furosemide · $1.1M import value · 23 shipments · UNITED STATES · DGFT Verified
ATHENEX PHARMACEUTICAL DIVISION is the #10 importer of Furosemide from India with $1.1M in import value and 23 verified shipments. ATHENEX PHARMACEUTICAL DIVISION holds a 1.6% market share in Furosemide imports based in UNITED STATES. The company sources from 1 verified supplier across 8 formulations shipped to 1 country.
ATHENEX PHARMACEUTICAL DIVISION — Furosemide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Furosemide to ATHENEX PHARMACEUTICAL DIVISION?
Verified from 23 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MAIVA PHARMA PRIVATE LIMITED | $1.1M | 23 | 100.0% |
ATHENEX PHARMACEUTICAL DIVISION sources Furosemide from 1 verified Indian supplier based on 23 customs records. The primary supplier is MAIVA PHARMA PRIVATE LIMITED accounting for 100.0% of imports.
How Does ATHENEX PHARMACEUTICAL DIVISION Compare to Nearest Furosemide Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | MARCAN PHARMACEUTICALS INC., | CANADA | $1.2M | 24 | $50.0K |
| 12 | NORTHSTAR DISTRIBUTION CENTER | UNITED STATES | $1.2M | 24 | $50.0K |
| 10 | ATHENEX PHARMACEUTICAL DIVISION ★ | UNITED STATES | $1.1M | 23 | $50.0K |
| 16 | EVERSANA | UNITED STATES | $1.0M | 20 | $50.0K |
| 18 | MINT PHARMACEUTICALS INC | CANADA | $750.0K | 15 | $50.0K |
ATHENEX PHARMACEUTICAL DIVISION ranks #10 among 778 Furosemide importers from India. Average shipment value of $50.0K compared to the market average of $39.5K. The closest competitors by value are MARCAN PHARMACEUTICALS INC., and NORTHSTAR DISTRIBUTION CENTER.
Where Does ATHENEX PHARMACEUTICAL DIVISION Import Furosemide To?
Destination countries from 23 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.1M | 23 | 100.0% |
ATHENEX PHARMACEUTICAL DIVISION imports Furosemide to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.1M.
What Furosemide Formulations Does ATHENEX PHARMACEUTICAL DIVISION Import?
| Formulation | Value | Shipments |
|---|---|---|
| FUROSEMIDE INJECTION USP 40MG PER 4 ML ( | $393.6K | 8 |
| FUROSEMIDE INJECTION USP 100MG PER 10ML | $349.6K | 7 |
| FUROSEMIDE INJECTION USP 40MG PER 4ML (F | $100.0K | 2 |
| FUROSEMIDE INJECTION USP 40MG PER 4ML F | $72.1K | 2 |
| FUROSEMIDE INJECTION USP 40MG PER 4ML FUROSEMIDE INJECTION USP 10MG PER ML BATCH NO E008A025 EXP DATE 11 2024 | $50.0K | 1 |
| FUROSEMIDE INJECTION USP 40MG PER 4ML FUROSEMIDE INJECTION USP 10MG PER ML BATCH NO E008A026 EXP DATE 11 2024 | $50.0K | 1 |
| FUROSEMIDE INJECTION USP 100MG PER 10ML FUROSEMIDE INJECTION USP 10MG PER ML BATCH NO E009A008 EXP DATE 05 2024 | $49.6K | 1 |
| FUROSEMIDE INJECTION USP 40MG PER 4ML FUROSEMIDE INJECTION USP 10MG PER ML BATCH NO E008A024 EXP DATE 11 2024 | $22.1K | 1 |
ATHENEX PHARMACEUTICAL DIVISION imports 8 distinct Furosemide formulations from India. The top formulation is FUROSEMIDE INJECTION USP 40MG PER 4 ML ( with 8 shipments worth $393.6K.
Regulatory Requirements: Importing Furosemide into United States
What ATHENEX PHARMACEUTICAL DIVISION and other importers must comply with to import Furosemide from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Furosemide
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Furosemide from India and How Much Does ATHENEX PHARMACEUTICAL DIVISION Import?
India exported $30.7M worth of Furosemide through 4,657 shipments from 333 suppliers to 150 countries, serving 778 buyers globally. ATHENEX PHARMACEUTICAL DIVISION imports $1.1M of this total, accounting for 1.6% of India's Furosemide exports with 23 shipments from UNITED STATES. This is verified from 23 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for ATHENEX PHARMACEUTICAL DIVISION's Furosemide Imports?
ATHENEX PHARMACEUTICAL DIVISION's average Furosemide order value is $47.3K per consignment, based on 23 shipments totaling $1.1M. ATHENEX PHARMACEUTICAL DIVISION is based in UNITED STATES and ranks #10 among all Furosemide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Furosemide to ATHENEX PHARMACEUTICAL DIVISION?
ATHENEX PHARMACEUTICAL DIVISION sources Furosemide from 1 verified Indian supplier: MAIVA PHARMA PRIVATE LIMITED ($1.1M, 100.0%). This is based on 23 customs records.
How Does ATHENEX PHARMACEUTICAL DIVISION Compare to Other Furosemide Importers?
ATHENEX PHARMACEUTICAL DIVISION ranks #10 among 778 Furosemide importers from India with a 1.6% market share. The top 3 importers are RISING PHARMA HOLDINGS, INC. ($6.3M), RISING PHARMA HOLDINGS INC ($4.2M), RISING PHARMA HOLDINGS INC,., ($3.6M). ATHENEX PHARMACEUTICAL DIVISION processed 23 shipments from UNITED STATES.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Furosemide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Furosemide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ATHENEX PHARMACEUTICAL DIVISION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ATHENEX PHARMACEUTICAL DIVISION's capped import value divided by total capped export value for Furosemide across all Indian exporters.
- 5.Verified Records: This page is backed by 23 individual customs records matching ATHENEX PHARMACEUTICAL DIVISION importing Furosemide, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 778+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Furosemide Import Data for ATHENEX PHARMACEUTICAL DIVISION
Access order-level details, pricing data, supplier connections, and competitive analysis for ATHENEX PHARMACEUTICAL DIVISION's Furosemide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ATHENEX PHARMACEUTICAL DIVISION
Company Profile
Multiple products · $0 total trade · Multiple categories
ATHENEX PHARMACEUTICAL DIVISION × Furosemide
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ATHENEX PHARMACEUTICAL DIVISION.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Furosemide. For current order-level data, contact TransData Nexus.